Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Amortizatization of Intangibles (2016 - 2017)

Bone Biologics has reported Amortizatization of Intangibles over the past 2 years, most recently at $1.2 million for Q4 2017.

  • Quarterly Amortizatization of Intangibles fell 13.85% to $1.2 million in Q4 2017 from the year-ago period, while the trailing twelve-month figure was $981659.0 through Dec 2017, down 19.65% year-over-year, with the annual reading at $340735.0 for FY2018, 89.76% down from the prior year.
  • Amortizatization of Intangibles was $1.2 million for Q4 2017 at Bone Biologics, up from $151680.0 in the prior quarter.
  • Over five years, Amortizatization of Intangibles peaked at $1.4 million in Q4 2016 and troughed at -$859521.0 in Q2 2017.